ATE359811T1 - Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe - Google Patents

Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Info

Publication number
ATE359811T1
ATE359811T1 AT00954737T AT00954737T ATE359811T1 AT E359811 T1 ATE359811 T1 AT E359811T1 AT 00954737 T AT00954737 T AT 00954737T AT 00954737 T AT00954737 T AT 00954737T AT E359811 T1 ATE359811 T1 AT E359811T1
Authority
AT
Austria
Prior art keywords
vaccines
trehalose
prokaryotic cells
producing prokaryotic
producing
Prior art date
Application number
AT00954737T
Other languages
English (en)
Inventor
Camilo Anthony Leo Selw Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of ATE359811T1 publication Critical patent/ATE359811T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT00954737T 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe ATE359811T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9919732.9A GB9919732D0 (en) 1999-08-19 1999-08-19 Trehalose producing cells as vaccines

Publications (1)

Publication Number Publication Date
ATE359811T1 true ATE359811T1 (de) 2007-05-15

Family

ID=10859499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954737T ATE359811T1 (de) 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Country Status (10)

Country Link
US (1) US20070243200A1 (de)
EP (1) EP1204420B1 (de)
AT (1) ATE359811T1 (de)
AU (1) AU6709500A (de)
DE (1) DE60034460T2 (de)
DK (1) DK1204420T3 (de)
ES (1) ES2286033T3 (de)
GB (1) GB9919732D0 (de)
PT (1) PT1204420E (de)
WO (1) WO2001013942A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8733289B2 (en) * 2008-04-07 2014-05-27 Rich Products Corporation Method for preparing edible aquatic animals for storage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312909A (en) * 1990-03-28 1994-05-17 Gist Brocades, N.V. Recombinant DNA encoding neutral trehalase
US5422254A (en) * 1992-02-14 1995-06-06 Oy Alko Ab Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby

Also Published As

Publication number Publication date
DE60034460D1 (de) 2007-05-31
WO2001013942A2 (en) 2001-03-01
US20070243200A1 (en) 2007-10-18
DE60034460T2 (de) 2008-01-03
PT1204420E (pt) 2007-07-20
ES2286033T3 (es) 2007-12-01
AU6709500A (en) 2001-03-19
DK1204420T3 (da) 2007-09-17
WO2001013942A3 (en) 2001-09-20
GB9919732D0 (en) 1999-10-20
EP1204420B1 (de) 2007-04-18
EP1204420A2 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ATE401097T1 (de) Verwendung von imidazochinolinaminen als adjuvantien in dna-impfung
DE69824013D1 (de) Impfstoff gegen hpv
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
PT1083903E (pt) Indenopirrolocarbazoles em ponte
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
ATE460923T1 (de) Lyophilisierung von virosomen
IL196900A (en) Autologous T cell vaccine compositions
DE60235836D1 (de) Ahren und verwendung davon
DK1278868T3 (da) Muteret form af arginindeiminase
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DE60118359D1 (de) Humanische pellino-polypeptide
BR0313135A (pt) Epìtopos de células t em eritropoietina
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE359811T1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE349520T1 (de) Gewebezementproteine aus rhipicephalus appendiculatus
ATE516045T1 (de) Identifikation von vaccinia-virus-dominanten t- zell-epitopen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204420

Country of ref document: EP